California’s highest court rules for Gilead, says drugmakers don’t have ’duty to innovate’
Investing.com· Reuters· Aug 3, 2026 · 6:54 PM
This is a summary. Read the complete story at Investing.com below.
Read full article at Investing.comRelated Stories
stocks37 minutes ago
Deutsche Bank sees cautious positioning despite market resilience
Investing.com
stocksabout 4 hours ago
UBS now expects AI capex to reach nearly $1tn this year and around $1.4tn by 2027
Investing.com
stocksabout 4 hours ago
US fashion council CEO Kolb resigns after clash with runway show protesters
Investing.com